Abstract | OBJECTIVE: MATERIALS AND METHODS: Fourteen patients and fourteen healthy age-matched controls were included in the study. The selenium, zinc and boron level in plasma and urine were measured by the inductively coupled plasma mass spectrometry. RESULTS: The plasma levels of zinc and selenium were significantly lower in both active and remission patients (for all p=0.0001). The plasma boron level was significantly lower only in patients in active phase (p=0.0002 vs control). The concentrations of urinary boron and selenium were significantly higher during active phase compared with remission (p=0.0003 and 0.0001, respectively). CONCLUSION: Supplementation with zinc, selenium and boron may be justified in patients suffering with this disease.
|
Authors | Sebahat Tulpar, Zubeyde Gunduz, Ugur Sahin, M Hakan Poyrazoglu, Ismail Dursun, Ruhan Dusunsel, Funda Bastug |
Journal | The Eurasian journal of medicine
(Eurasian J Med)
Vol. 46
Issue 3
Pg. 187-91
(Oct 2014)
ISSN: 1308-8734 [Print] Turkey |
PMID | 25610323
(Publication Type: Journal Article)
|